Skip to content

Mechanism of long-chain non-coding RNA involved in perioperative neurocognitive disorders in elderly patients undergoing total knee or total hip arthroplasty

Mechanism of long-chain non-coding RNA involved in perioperative neurocognitive disorders in elderly patients undergoing total knee or total hip arthroplasty

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900028087
Enrollment
Unknown
Registered
2019-12-11
Start date
2020-01-01
Completion date
Unknown
Last updated
2021-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative neurocognitive impairment

Interventions

Case series:Nil

Sponsors

The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Aged > 65 years; 2. Patients undergoing total knee or hip arthroplasty (elderly patients with joint replacement are prone to PND); 3. ASA was classified as grade I or II (reducing the interference of complications); 4. Have junior high school or above education level (can read various scales); 5. Clearly understand and volunteer to participate in the study, and sign the informed consent by the person or legal client.

Exclusion criteria

Exclusion criteria: 1. Acute heart failure; unstable angina pectoris; myocardial infarction within 6 months before screening; resting electrocardiogram heart rate 2.5 ULN), TBIL (> 1.5 ULN); 6. Renal dysfunction: urea or urea nitrogen (> 1.5 ULN), serum creatinine greater than the upper limit of normal value; 7. There were history of drug abuse, drug abuse and alcoholism in the two years before the screening period. Alcohol abuse was more than 2 units of alcohol per day (1 unit = 360 mL beer or 45 mL alcohol 40% white wine or 150 mL wine); 8. Patients who did not receive regular antihypertensive therapy or poor blood pressure control (seated systolic blood pressure (> 180 mmHg or 105 mmHg) during screening; 9. Benzodiazepines and/or anticholinergics were discontinuously administered daily for one month or nearly three months; 10. Anaphylaxis or contraindication to benzodiazepines, opioids, propofol, etc. 11. The researchers did not consider it appropriate for patients to participate in the trial.

Design outcomes

Primary

MeasureTime frame
lncRNA;Incidence of PND;

Countries

China

Contacts

Public ContactKeqiang He

The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China

doctorhector@ustc.edu.cn+86 18955197569

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026